The Diabetes and Thyroid Center of Fort Worth Clinical Research Department is committed to providing excellent clinical research support for our patients and our practice community. Our mission is to provide our patients with access to the newest medications and best options available in the treatment of their conditions. DTC has participated in many important clinical trials in the field of type 2 diabetes and lipid therapy.
We are always looking for study participants and currently enrolling for multiple clinical trials.
Clinical Trial Research
Download Research New Patient Packet
If you are interested in participating or think you may qualify for one of the trials listed below, please contact our research team. Call us at 817-779-4478 or email research@dtc-fw.com. We would be happy to provide you with more information or complete an evaluation!
OUR CURRENT ENROLLING TRIALS
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants wit Body Mass Index >=27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Kidney Disease (TRIUMPH-Outcomes Trial)
CLICK HERE
- A research study on the efficacy and safety of Armour Thyroid Treatment in Subjects with Primary Hypothyroidism
CLICK HERE
- A Dose Ranging Study to Investigate Efficacy and Safety of Subcutaneous TOUR006 Compared with Placebo in Participants 18 to 80 Years of Age Inclusive with Thyroid Eye Disease (Tourmaline)
CLICK HERE